Poland· PL-100420970
Furaginum Hasco Forte
A furazidin product containing furazidinum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Furazidinum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- J01XE03
- ATC class
- Furazidin
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991448745
- gtin05909991448752
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J01XE03
Furazidin, as other registers publish it.
- PolandDafuragAflofarm Farmacja Polska Sp. z o.o.
- PolandDafurag maxAflofarm Farmacja Polska Sp. z o.o.
- PolandFuragina APTEO MEDSynoptis Pharma Sp. z o.o.
- PolandFuragina FORTE APTEO MEDSynoptis Pharma Sp. z o.o.
- PolandFuraginum AdamedAdamed Pharma S.A.
- PolandFuraginum HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandFuraginum HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandFuraginum Hasco MaxPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Latvia · Furagins, Furasol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e31b067-0e0c-4832-af7b-9ae3a6d842dc GET /v1/drugs/0e31b067-0e0c-4832-af7b-9ae3a6d842dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "100 mg/5 ml",
"packaging": "05909991448745 ¦ Rp ¦ 139319\n1 butelka 100 ml\n05909991448752 ¦ Rp ¦ 139320\n1 butelka 140 ml",
"substance": "Furazidinum 100 mg/5 ml",
"common_name": "Furazidinum",
"pl_product_id": "100420970",
"pozwolenie_nr": "26376",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about furazidin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.